The 103D6 monoclonal antibody is a mouse IgG2c inhibitor targeting mouse osteopontin (SPP1). It is a valuable tool for investigating the role of SPP1 in bone metabolism, cancer progression, and immune responses in both cell-based assays and animal models.
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted